A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis
Titel:
A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis
Auteur:
Brufsky, A. Kim, S.B. Zvirbule, Ž. Eniu, A. Mebis, J. Sohn, J.H. Wongchenko, M. Chohan, S. Amin, R. Yan, Y. McNally, V. Miles, D. Loi, S.